TNSN98126A1 - Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan - Google Patents

Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan

Info

Publication number
TNSN98126A1
TNSN98126A1 TNTNSN98126A TNSN98126A TNSN98126A1 TN SN98126 A1 TNSN98126 A1 TN SN98126A1 TN TNSN98126 A TNTNSN98126 A TN TNSN98126A TN SN98126 A TNSN98126 A TN SN98126A TN SN98126 A1 TNSN98126 A1 TN SN98126A1
Authority
TN
Tunisia
Prior art keywords
pharmaceutical compositions
compositions containing
eletriptan hemisulfate
containing eletriptan
hemisulfate
Prior art date
Application number
TNTNSN98126A
Other languages
English (en)
French (fr)
Inventor
Billotte Anne
Denise Harding Valerie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN98126A1 publication Critical patent/TNSN98126A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
TNTNSN98126A 1997-07-03 1998-07-01 Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan TNSN98126A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TNSN98126A1 true TNSN98126A1 (fr) 2005-03-15

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98126A TNSN98126A1 (fr) 1997-07-03 1998-07-01 Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan

Country Status (13)

Country Link
KR (1) KR100384346B1 (ko)
AP (1) AP1100A (ko)
AR (1) AR013165A1 (ko)
CO (1) CO4950555A1 (ko)
GB (2) GB9714081D0 (ko)
GT (1) GT199800105A (ko)
HN (1) HN1998000101A (ko)
MY (1) MY119643A (ko)
PA (1) PA8454501A1 (ko)
PE (1) PE84499A1 (ko)
TN (1) TNSN98126A1 (ko)
UA (1) UA49955C2 (ko)
ZA (1) ZA985812B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
UA49955C2 (uk) 2002-10-15
GB9718270D0 (en) 1997-11-05
AP9801290A0 (en) 1998-09-30
MY119643A (en) 2005-06-30
PA8454501A1 (es) 2000-05-24
GT199800105A (es) 2000-01-04
CO4950555A1 (es) 2000-09-01
PE84499A1 (es) 1999-09-11
AR013165A1 (es) 2000-12-13
ZA985812B (en) 2000-01-10
HN1998000101A (es) 1999-01-08
KR100384346B1 (ko) 2003-05-16
GB9714081D0 (en) 1997-09-10
KR20010014366A (ko) 2001-02-26
AP1100A (en) 2002-09-02

Similar Documents

Publication Publication Date Title
DZ2549A1 (fr) Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan.
Goodfield Short‐duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trial
BE1002249A4 (fr) Compositions pharmaceutiques.
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA27729A1 (fr) Compositions pharmaceutiques solides contenant un agoniste des recepteurs de la s1p et un alcool de sucre
TNSN97044A1 (fr) Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.
TNSN98182A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97078A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98066A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN96172A1 (fr) Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99170A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98227A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant.
EA200000299A1 (ru) Лекарства
TNSN97087A1 (fr) 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
MA26702A1 (fr) Compositions pharmaceutiques pour le traitement de la migraine, et procede pour leur preparation
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN01173A1 (fr) Compositions pharmaceutiques comprenant un antagoniste des recepteurs de nmda.
TNSN02018A1 (fr) COMPOSITIONS COMPRENANT UN AGONISTE INVERSE DE GABAa, ET UN AGONISTE PARTIEL DES RECEPTEURS DE NICOTINE, UN OESTROGENE, UN MODULATEUR SELECTIF DES RECEPTEURS D'OESTROGENE OU DE LA VITAMINE E
TNSN98104A1 (fr) Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2231558A1 (fr) Ligand antagoniste rar-.gamma. ou agoniste rar-.alpha. en tant qu'inhibiteur d'apoptose